Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

838 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A position paper: based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer's Disease Cholesterol-Lowering Treatment Trial (ADCLT).
Sparks DL, Lopez J, Connor D, Sabbagh M, Seward J, Browne P; Alzheimer's Disease Cholesterol-Lowering Treatment Team. Sparks DL, et al. Among authors: sabbagh m. J Mol Neurosci. 2003;20(3):407-10. doi: 10.1385/JMN:20:3:407. J Mol Neurosci. 2003. PMID: 14501025 Clinical Trial.
Smoking affects the phenotype of Alzheimer disease.
Sabbagh MN, Tyas SL, Emery SC, Hansen LA, Alford MF, Reid RT, Tiraboschi P, Thal LJ. Sabbagh MN, et al. Neurology. 2005 Apr 12;64(7):1301-3. doi: 10.1212/01.WNL.0000156912.54593.65. Neurology. 2005. PMID: 15824373
The use of memantine in dementia with Lewy bodies.
Sabbagh MN, Hake AM, Ahmed S, Farlow MR. Sabbagh MN, et al. J Alzheimers Dis. 2005 Aug;7(4):285-9. doi: 10.3233/jad-2005-7403. J Alzheimers Dis. 2005. PMID: 16131729
838 results